GLP1R and stroke disorder: Evidence has demonstrated the protective role of GLP-1 receptor agonists in the cardiovascular system, decreasing abdominal visceral fat and systolic blood pressure, and improving endothelial and myocardial function [372], which ultimately reduces non-fatal stroke and the incidence of stroke and myocardial infarction [363,373].